BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10688671)

  • 1. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.
    Huang S; Brandt SJ
    Mol Cell Biol; 2000 Mar; 20(6):2248-59. PubMed ID: 10688671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein.
    Huang S; Qiu Y; Stein RW; Brandt SJ
    Oncogene; 1999 Sep; 18(35):4958-67. PubMed ID: 10490830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL.
    Huang S; Qiu Y; Shi Y; Xu Z; Brandt SJ
    EMBO J; 2000 Dec; 19(24):6792-803. PubMed ID: 11118214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
    Cai Y; Xu Z; Xie J; Ham AJ; Koury MJ; Hiebert SW; Brandt SJ
    Biochem Biophys Res Commun; 2009 Dec; 390(2):295-301. PubMed ID: 19799863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
    Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of basic helix-loop-helix protein-containing complexes during erythroid differentiation.
    Lister JA; Baron MH
    Gene Expr; 1998; 7(1):25-38. PubMed ID: 9572395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis.
    Hu X; Li X; Valverde K; Fu X; Noguchi C; Qiu Y; Huang S
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10141-6. PubMed ID: 19497860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
    O'Neil J; Shank J; Cusson N; Murre C; Kelliher M
    Cancer Cell; 2004 Jun; 5(6):587-96. PubMed ID: 15193261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tal1/SCL binding to pericentromeric DNA represses transcription.
    Wen J; Huang S; Pack SD; Yu X; Brandt SJ; Noguchi CT
    J Biol Chem; 2005 Apr; 280(13):12956-66. PubMed ID: 15677454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
    Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
    J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.
    Condorelli G; Vitelli L; Valtieri M; Marta I; Montesoro E; Lulli V; Baer R; Peschle C
    Blood; 1995 Jul; 86(1):164-75. PubMed ID: 7540882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
    Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
    Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SCL gene product: a positive regulator of erythroid differentiation.
    Aplan PD; Nakahara K; Orkin SH; Kirsch IR
    EMBO J; 1992 Nov; 11(11):4073-81. PubMed ID: 1396592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
    Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
    Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
    Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
    J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers.
    Bernard M; Delabesse E; Smit L; Millien C; Kirsch IR; Strominger JL; Macintyre EA
    Int Immunol; 1998 Oct; 10(10):1539-49. PubMed ID: 9796921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.